Risk Stratification After Acute Myocardial Infarction With Cardiac MRI (CR-2280)
Risk Stratification for Sudden Cardiac Death After Acute Myocardial Infarction by Measuring Left Ventricular Volume Scar With Cardiac MRI
Sponsor: Medtronic
This observational or N/A phase trial investigates Acute Myocardial Infarction (AMI) and is currently completed. Medtronic leads this study, which shows 5 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Nov 2018 — Jan 2021 [monthly]
Completed
First recorded
May 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic
- Montefiore Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .